Galmed reports results from the Open-Label part of the ARMOR study showing improvements in histology, imaging, and biomarkers with Aramchol Histological improvement in fibrosis (≥1 stage) was demonstrated in 39% of subjects according...

The liquid biopsy has been developed by Datar Cancer Genetics to help diagnose brain tumors where a conventional biopsy is not possible. A prospective, blinded study by a research team at the Imperial College, London showed very high...

Paige Breast Suite has been introduced to support pathologists in overcoming these challenges, as well as offer enhanced efficiency and confidence. Breast cancer diagnosis is uniquely complex and poses many challenges for pathologists. In...

Proscia: Pathology’s transition from glass slides to digital images has opened a huge frontier, enabling the application of artificial intelligence (AI) to improve everything from workflow efficiency to patient outcomes. However, developing...

The history of Leica Biosystems is a history of science and technology innovation. For 150+ years, we’ve tackled pathology challenges head-on – from company founder Rudolf Jung building the first microtome to today’s world-leading...

Akoya: New products and partnerships further accelerate and simplify identification of actionable spatial signatures, creating unprecedented opportunities to improve patient outcomes Ready-to-use panels, turnkey software solutions, and...